Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $5.4 billion.

  • Bristol Myers Squibb's Long-Term Deferred Tax rose 2695.94% to $5.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.4 billion, marking a year-over-year increase of 2695.94%. This contributed to the annual value of $5.4 billion for FY2025, which is 2695.94% up from last year.
  • Bristol Myers Squibb's Long-Term Deferred Tax amounted to $5.4 billion in Q4 2025, which was up 2695.94% from $5.0 billion recorded in Q3 2025.
  • Bristol Myers Squibb's Long-Term Deferred Tax's 5-year high stood at $5.4 billion during Q4 2025, with a 5-year trough of $650.0 million in Q2 2021.
  • For the 5-year period, Bristol Myers Squibb's Long-Term Deferred Tax averaged around $2.5 billion, with its median value being $1.5 billion (2023).
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first plummeted by 4025.74% in 2021, then skyrocketed by 13837.52% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Long-Term Deferred Tax (Quarter) stood at $1.4 billion in 2021, then decreased by 6.6% to $1.3 billion in 2022, then soared by 105.95% to $2.8 billion in 2023, then soared by 53.03% to $4.2 billion in 2024, then rose by 26.96% to $5.4 billion in 2025.
  • Its last three reported values are $5.4 billion in Q4 2025, $5.0 billion for Q3 2025, and $4.6 billion during Q2 2025.